However, in the first quarter of 2020, their revenue growth slowed all the way down to 290%, so they only produced $27 million in revenue. 10 stocks we like better than Inari Medical, Inc. Glassdoor kann nur dann sinnvoll benutzt werden, wenn Ihr Browser Cookies zulässt. So, example: When we talk about companies like And they have lots of completely gross photos on their website where you can go and check out blood clots that have been removed from actual patients' bodies to show that the technology is the real deal.But the exciting thing here, Jason, is even though this company just got FDA approval in 2018, I mean, we're not even talking about two years -- the numbers that they're throwing up already are extremely exciting.
Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. But yeah, so this is Inari Medical, the ticker symbol is NARI, just came public in May of this year. Gross margin, 88% already. It sounds like they'd be the same thing, but Inari points out that veins and arteries are different. Retirement
We don't have any interview reviews for Inari Medical. Glassdoor is your free inside look at bonus trends for Inari Medical & over 250,000 other companies. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic.
We would like to show you a description here but the site won’t allow us. glassdoor.com sales-marketing marketing coordinator Marketing Coordinator Inari Medical is a medical device company in Orange County, California that designs, develops, manufactures and sells innovative devices for the interventional treatment of vascular thrombi and emboli. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. You would expect that this company would be a cash-burning machine; just an absolute furnace of that.
Investing Basics
Here for you during COVID-19 At Glassdoor, our mission is to help you find a job and company you love. Select your job title and find out how much you could make at Inari Medical.
It is so rare to see companies that, basically, a year after FDA approval, are already profitable.So let me just review a couple of their numbers; see if any of these capture your attention. See all of Veins are low flow, low pressure. Again, revenue last year was about $50 million, but it's growing very quickly. Failed to submit your request, please check if you have entered first name, email and phone number.Thank you for your request. So they're designed to take blood clots out of arteries. Otherwise, the company's revenue would not be growing nearly this quickly.So that's absolutely a risk that investors need to be aware of that those competitors will develop competing products or that the company may struggle to grow past the initial core group of users. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Bewertung zu Zusatzleistung posten und diese Seite in Schwung bringen. View the latest Inari Medical Inc. (NARI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Tell us who you are and a Glassdoor Sales Representative will get back to you right away. And clots can appear in veins for a huge number of reasons. This is the Inari company profile. And these are a major, major problem.And so, everybody I have ever spoken [to] with issues like this, I mean, it sounds like most are being prescribed some type of medicine, some type of drug that is helping to thin the blood. And the risk of developing one of these skyrockets if you are obese, if you smoke, or if you are a little bit older.